Barclays Maintains Overweight on Expro, Lowers Price Target to $19

Benzinga Newsdesk www.benzinga.com Negative 85.3%

Neg 85.3% Neu 0% Pos 0%

Barclays analyst David Anderson maintains Expro (NYSE:XPRO) with a Overweight and lowers the price target from $20 to $19.